The Pharmacy Times® Zoster Resource Center is a comprehensive resource for clinical news and expert insights on the reactivation of the chickenpox virus in the body, which causes a painful rash.
Shingles Vaccination May Reduce Risk of Stroke
In a recent study, researchers found that Zoster Vaccine Live, a type of shingles vaccine, may prevent stroke in some older adults.
Shingles Vaccine Becoming Increasingly Common Among Older Adults
Although shingles can affect any age group, risks increase with age.
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Vitamin C and Zinc
Vitamin C and zinc are among the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Vaccinations Once Again Available at All Giant Food Pharmacies
Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.
Advocacy: An Essential Skill for the Modern Pharmacy Student
People have many reasons for wanting to become a pharmacist, ranging from personal encounters with pharmacists and witnessing experiences of friends and family members to stories they have read online about the profession.
Same Herpes Zoster Virus as First Infection Causes Recurrent Shingles
In a study, polymerase chain reaction–confirmed second episodes of herpes zoster occurred in 2 of 660 patients receiving a placebo and 1 of 321 patients receiving ZVL.
Cost of Herpes Zoster, Complications May Hit $2.4 Billion Annually in United States
Two shingles vaccines are licensed and recommended in the United States.
Study: Household Exposure to Varicella Reduces Risk of Shingles in Adults
The investigators identified patients with a first-ever diagnosis of zoster who also had a child in the household with a varicella record.
Immunizing Those With Diabetes Requires Special Considerations
Rates of some vaccinations are low in these patients, but pharmacists can play a key role in adherence.
Exploring Techniques to Increase Vaccination Rates Among Adult Patients with Chronic Disease
Immunization needs for patients aged 19 to 64 years and afflicted with chronic conditions are often overlooked, and necessitate more attention and resources. Pharmacies traditionally do not focus on this patient population; instead often choosing to focus primarily on the population 65 years and over. However, engaging with patients in the 19- to 64-year-old group could go a long way in helping to fill the current immunization void in this population.
Study Finds Live Zoster Vaccine Safe, Effective in Patients Taking TNF Inhibitors
The study evaluated the safety and efficacy of a live, attenuated zoster vaccine patients receiving tumor necrosis factor inhibitor therapies for various indications.
The Community Pharmacist as a Provider of Immunizations
Community pharmacies that provide immunization services have proven their success time and again, but they still face roadblocks. Many state laws and regulations still do not allow pharmacies to take full responsibility for vaccinations, and states regulate immunization services at pharmacies in different ways.
Immunizing Patients Is Worth Pharmacists' and Technicians' Time
Life-saving vaccines have had a profound impact in this country and worldwide. According to the CDC, from 2006 to 2017, almost 3.5 billion doses of vaccines were distributed in the United States.
Healthy People 2020: Immunization Goals
The goal of the Healthy People initiative is to “provide science-based, 10-year national objectives for improving the health of all Americans.”
The Impact of Community Pharmacies on Immunization
The community pharmacist wears multiple hats in the daily delivery of health care to patients, one of which might be providing immunization services. Certainly, the patient who walks in for an immunization benefits from the convenience provided by the community pharmacy.
It Is Time to Go to Bat for Community Pharmacies
They have become more important in health care delivery yet represent a smaller portion of the bill.
Immunizing the 19- to 64-Year-Old Population With Chronic Disease
The most common chronic conditions, and the biggest drivers in annual health care costs for US adults, include heart disease, cancer, chronic lung disease, diabetes, and chronic kidney disease.
A Pharmacist's Guide to Identifying the Signs and Symptoms of Herpes Zoster
Herpes zoster, also known as zoster or shingles, is caused by the reactivation of the varicella zoster virus. After an individual has been exposed to the varicella virus through chickenpox or via vaccination, the virus remains dormant in the dorsal root ganglia.
Herpes Zoster Vaccination: Recent Advancements and Recommendations
Herpes zoster, commonly known as shingles, is characterized by a painful, itchy rash and blisters, often resulting in permanent neuropathic pain (postherpetic neuralgia) that can be difficult to manage.
Seizing Patient Education Opportunities and Recognizing Precautions for Herpes Zoster Vaccination
Pharmacists are now core members of the vaccination community, playing a role in vaccine accessibility, opportunity, identification, and safety.
Patient Engagement Strategies for Immunization in a Community Pharmacy Setting
Prior to vaccines, immunity to a disease was acquired solely through contracting the illness.
FDA Approves New Herpes Zoster Vaccine
Singrix is a recombinant vaccine indicated for the prevention of herpes zoster in older adults.
Asthma: An Unrecognized Risk Factor for Shingles
Herpes zoster, also known as shingles, is a painful rash caused by a reactivation of the varicella-zoster virus, also called the chickenpox virus.
Severe Adverse Event Warnings Added to Picato Gel Label
Ingenol mebutate (Picato) gel's label must now include reported risks of shingles and anaphylaxis.
Postinfection Complications: Vigilance at the Counter
Vigilant pharmacists can help patients identify postinfection complications.
Patients Protected by Shingles Vaccine After Chemotherapy
Shingles Vaccine Contraindicated in Patients at Greatest Risk
Stroke Risk Increases in Months Following Shingles
Varicella-Zoster Virus: An Ounce of Prevention Does Not Equal a Cure
The impact of varicella-zoster virus vaccination programs on the US population is not yet clear.
2 Clarke Drive Cranbury, NJ 08512